2020
DOI: 10.1093/arclin/acaa016
|View full text |Cite
|
Sign up to set email alerts
|

Are Established Embedded Performance Validity Test Cut-Offs Generalizable to Patients With Multiple Sclerosis?

Abstract: Objective Data for the use of embedded performance validity tests (ePVTs) with multiple sclerosis (MS) patients are limited. The purpose of the current study was to determine whether ePVTs previously validated in other neurological samples perform similarly in an MS sample. Methods In this retrospective study, the prevalence of below-criterion responding at different cut-off scores was calculated for each ePVT of interest amo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 13 publications
0
10
0
Order By: Relevance
“…Current findings suggested specificities for these variables ranged from 0.80-0.90 and 0.90-0.92, respectively. Although the specificity for C-FCR ≤ 15 was 0.98 as reported by Domen and colleagues [38], these results suggested that 20% (i.e., specificity = 0.80) of the credible group were misidentified as noncredible, suggesting that a more conservative cutoff of ≤14 [37] may yield fewer false positives. Additionally, these results further extend Domen and colleagues' [38] research as they revealed that specificities for C-RH and B-RH-neither of which were discussed by Domen and colleagues [38]-hovered around 0.90 (0.89-0.95).…”
Section: Discussionmentioning
confidence: 58%
See 4 more Smart Citations
“…Current findings suggested specificities for these variables ranged from 0.80-0.90 and 0.90-0.92, respectively. Although the specificity for C-FCR ≤ 15 was 0.98 as reported by Domen and colleagues [38], these results suggested that 20% (i.e., specificity = 0.80) of the credible group were misidentified as noncredible, suggesting that a more conservative cutoff of ≤14 [37] may yield fewer false positives. Additionally, these results further extend Domen and colleagues' [38] research as they revealed that specificities for C-RH and B-RH-neither of which were discussed by Domen and colleagues [38]-hovered around 0.90 (0.89-0.95).…”
Section: Discussionmentioning
confidence: 58%
“…Although the specificity for C-FCR ≤ 15 was 0.98 as reported by Domen and colleagues [38], these results suggested that 20% (i.e., specificity = 0.80) of the credible group were misidentified as noncredible, suggesting that a more conservative cutoff of ≤14 [37] may yield fewer false positives. Additionally, these results further extend Domen and colleagues' [38] research as they revealed that specificities for C-RH and B-RH-neither of which were discussed by Domen and colleagues [38]-hovered around 0.90 (0.89-0.95). Current findings support their conclusion that various previously validated cutoff scores may avoid excessive false-positive errors in patients with MS.…”
Section: Discussionmentioning
confidence: 58%
See 3 more Smart Citations